Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | nadolol | 39147 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | nadolol | 39147 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | nadolol | 39147 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | nadolol | 39147 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | nadolol | 39147 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | nadolol | 39147 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | nadolol | 39147 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | nadolol | 39147 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | nadolol | 39147 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | nadolol | 39147 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | harmol | 101616 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | harmol | 101616 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | harmol | 101616 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | harmol | 101616 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | harmol | 101616 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | harmol | 101616 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | harmol | 101616 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | harmol | 101616 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | harmol | 101616 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | harmol | 101616 | drug-path |